Anticholinergic delirium possibly associated with protriptyline and fluoxetine.
Paul
K L
KL
Bhatara
V S
VS
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D018680:Cholinergic Antagonists / Q000009:adverse effects*; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D003693:Delirium / Q000139:chemically induced* / Q000188:drug therapy / Q000201:enzymology; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006212:Hallucinations / Q000139:chemically induced; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D011530:Protriptyline / Q000009:adverse effects*
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D018680:Cholinergic Antagonists; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D005473:Fluoxetine; D011530:Protriptyline; D006220:Haloperidol